window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

UK biotech

  • Biotech,Cell & Gene Therapy,Clinical Trials,Mergers & Acquisitions

    Alvarez & Marsal appointed to oversee TC BioPharm as sale of business and assets begins

    Alvarez & Marsal has been appointed as joint administrators of [...]

    October 8, 2025
  • Rare Diseases,Research & Development

    Princess Royal opens new Insmed research facility in Cambridge focused on synthetic rescue

    Insmed has officially opened a new $10M, 17,000-square-foot research and [...]

    July 22, 2025
  • Artificial Intelligence,Drug Development,Market Access & Commercialization,Partnerships & Funding

    Optibrium secures multi-million-pound funding to power global AI drug discovery expansion

    Backing from Shawbrook follows rapid customer growth and positions Optibrium [...]

    July 8, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy,Drug Delivery & Formulation

    N4 Pharma reports positive in vivo results from oral IBD gene therapy study using Nuvec

    UK-based biotech N4 Pharma has announced encouraging in vivo results [...]

    June 8, 2025
  • Partnerships & Funding,Technology and platforms

    MindSpire secures £850K to launch SONA wearable and revolutionise stress management with AI-driven vagus nerve tech

    Neurotech start-up MindSpire has raised £850,000 in pre-seed funding to [...]

    May 10, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top